[go: up one dir, main page]

PE39599A1 - Dispositivo de inhalacion - Google Patents

Dispositivo de inhalacion

Info

Publication number
PE39599A1
PE39599A1 PE1998000011A PE00001198A PE39599A1 PE 39599 A1 PE39599 A1 PE 39599A1 PE 1998000011 A PE1998000011 A PE 1998000011A PE 00001198 A PE00001198 A PE 00001198A PE 39599 A1 PE39599 A1 PE 39599A1
Authority
PE
Peru
Prior art keywords
dosage
dose
deposit
user
communicated
Prior art date
Application number
PE1998000011A
Other languages
English (en)
Inventor
Peter John Brand
Etienne Seguelas
Bosko Dmitrovic
David Buday-Goldberger
Paul Kenneth Rand
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE39599A1 publication Critical patent/PE39599A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/007—Mechanical counters
    • A61M15/0071—Mechanical counters having a display or indicator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Closures For Containers (AREA)
  • Medicinal Preparation (AREA)
  • Manipulator (AREA)
  • Catching Or Destruction (AREA)

Abstract

QUE COMPRENDE: A) UN CUERPO QUE DEFINE UN DEPOSITO PARA MEDICAMENTO EN LA FORMA DE UN POLVO; B) UNA SALIDA A TRAVES DE LA CUAL UN USUARIO PUEDE INHALAR; Y C) UN MIEMBRO DE DOSIFICACION, CON AL MENOS UN REBAJO DE DOSIFICACION FORMADO EN EL MISMO, QUE ES MOVIBLE ENTRE UNA PRIMERA POSICION EN LA CUAL AL MENOS UN REBAJO DE DOSIFICACION SE COMUNICA CON EL DEPOSITO PARA RECIBIR UNA DOSIS DE POLVO DESDE EL MISMO, Y UNA SEGUNDA POSICION EN LA CUAL AL MENOS UN REBAJO DE DOSIFICACION SE COMUNICA CON LA SALIDA PARA PERMITIR AL USUARIO INHALAR LA DOSIS, ADEMAS AL MENOS UN REBAJO DE DOSIFICACION ESTA FORMADO EN UNA CARA O SUPERFICIE DEL MIEMBRO DE DOSIFICACION QUE SE PRESIONA PARA PONERSE EN CONTACTO CONTRA UNA SUPERFICIE O CARA DE ACOPLAMIENTO SIMILAR DEL CUERPO EN EL EXTREMO INFERIOR DEL DEPOSITO PARA FORMAR UN SELLO DINAMICO, CARACTERIZADO EN QUE AL MENOS UNA DE DICHAS CARAS O SUPERFICIES SE HACE DE UN MATERIAL FLEXIBLE QUE TIENE UNA DUREZA DE MENOS DE 80 SHORE A Y UN COEFICIENTE DE FRICCION DE 0,4 O MENOS. DICHO DISPOSITIVO SE USA PARA DISPERSAR DOSIS MEDIDAS DE MEDICAMENTO EN LA FORMA DE POLVO A UN USUARIO
PE1998000011A 1997-01-08 1998-01-06 Dispositivo de inhalacion PE39599A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9700226.5A GB9700226D0 (en) 1997-01-08 1997-01-08 Inhalation device

Publications (1)

Publication Number Publication Date
PE39599A1 true PE39599A1 (es) 1999-05-05

Family

ID=10805635

Family Applications (2)

Application Number Title Priority Date Filing Date
PE1998000011A PE39599A1 (es) 1997-01-08 1998-01-06 Dispositivo de inhalacion
PE2001000783A PE20030179A1 (es) 1997-01-08 2001-08-07 Dispositivo de inhalacion

Family Applications After (1)

Application Number Title Priority Date Filing Date
PE2001000783A PE20030179A1 (es) 1997-01-08 2001-08-07 Dispositivo de inhalacion

Country Status (28)

Country Link
US (1) US6321747B1 (es)
EP (2) EP1378260B1 (es)
JP (1) JP2001507966A (es)
KR (1) KR20000069973A (es)
CN (2) CN1249694A (es)
AP (2) AP1165A (es)
AR (2) AR011372A1 (es)
AT (2) ATE279954T1 (es)
BR (1) BR9806864A (es)
CA (1) CA2277150A1 (es)
CO (1) CO5080756A1 (es)
CZ (1) CZ2000298A3 (es)
DE (2) DE69831517T2 (es)
EA (2) EA001286B1 (es)
GB (1) GB9700226D0 (es)
HR (1) HRP980382B1 (es)
HU (1) HU222771B1 (es)
ID (1) ID22851A (es)
IL (1) IL130687A (es)
IS (1) IS5103A (es)
NO (1) NO993348D0 (es)
NZ (1) NZ336507A (es)
PE (2) PE39599A1 (es)
PL (2) PL187815B1 (es)
TR (2) TR200000032T2 (es)
TW (1) TW404843B (es)
WO (1) WO1998030262A2 (es)
YU (1) YU32399A (es)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69529104T2 (de) * 1994-09-16 2003-07-17 Laboratoire Glaxosmithkline S.A.S., Marly-Le-Roi Inhalator
JPH11122624A (ja) 1997-10-16 1999-04-30 Matsushita Electric Ind Co Ltd ビデオデコーダ処理量を低減する方法および装置
AU777278B2 (en) * 1999-06-05 2004-10-07 Innovata Biomed Limited Delivery system
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
DE19961300A1 (de) * 1999-12-18 2001-06-21 Asta Medica Ag Vorratssystem für Arzneimittel in Pulverform und damit ausgestatteter Inhalator
WO2001078735A1 (en) * 2000-04-13 2001-10-25 Innovata Biomed Limited Medicaments for treating respiratory disorders comprising formoterol and fluticasone
GB0015034D0 (en) 2000-06-21 2000-08-09 Glaxo Group Ltd Inhalation device
PE20020163A1 (es) * 2000-06-23 2002-03-04 Norton Healthcare Ltd Sistema presurizado de receptaculo para inhalador de medicamento
GB0019715D0 (en) 2000-08-10 2000-09-27 Pa Consulting Services Device for delivering physiologically active agent in powdered form
SE517229C2 (sv) * 2000-09-25 2002-05-14 Microdrug Ag Kontinuerlig inhalator för torrt pulver
GB0109717D0 (en) * 2001-04-20 2001-06-13 Glaxo Group Ltd Medicament dispenser
FI20011317A0 (fi) 2001-06-20 2001-06-20 Orion Corp Jauheinhalaattori
US20040244794A1 (en) * 2001-08-09 2004-12-09 Richards David Hugh Inhalation device with a pharmaceutical composition
JP4261351B2 (ja) * 2001-09-19 2009-04-30 アドヴェント ファーマセウティカルズ プロプライエタリー リミテッド 吸入器
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
US7258118B2 (en) * 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
AU2003222642A1 (en) * 2002-05-10 2003-11-11 Chrysalis Technologies Incorporated Aerosol generator for drug formulation and methods of generating aerosol
EP1539286B1 (de) * 2002-09-16 2015-01-21 Sanofi SA Inhalator für pulverförmige, insbesondere medizinische substanzen
JP2006506373A (ja) * 2002-10-22 2006-02-23 グラクソ　グループ　リミテッド 医薬アリールエタノールアミン化合物
AU2003286143A1 (en) 2002-10-28 2004-05-13 Glaxo Group Limited Phenethanolamine derivative for the treatment of respiratory diseases
GB0303396D0 (en) * 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds
FR2858867B1 (fr) * 2003-08-12 2005-11-04 Valois Sa Indicateur de doses pour dispositif de distribution de produit fluide
GB0324886D0 (en) * 2003-10-24 2003-11-26 Glaxo Group Ltd Medicinal compounds
US20070053843A1 (en) * 2003-10-28 2007-03-08 Dawson Michelle L Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
GB0329182D0 (en) * 2003-12-17 2004-01-21 Glaxo Group Ltd Chemical compounds
AU2005227733A1 (en) * 2004-04-02 2005-10-13 Glaxo Group Limited Chemical process and new crystalline form
JP2007533387A (ja) 2004-04-21 2007-11-22 イノベータ バイオメド リミテッド 吸入器
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
SE0401773D0 (sv) * 2004-07-02 2004-07-02 Astrazeneca Ab An inhalation and a method for assemnling said inhalation device
EP1846374A1 (en) * 2005-01-11 2007-10-24 Glaxo Group Limited Cinnamate salts of a beta-2 adrenergic agonist
EP3199164B1 (en) 2005-02-10 2020-03-18 Glaxo Group Limited Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
WO2006086130A2 (en) * 2005-02-10 2006-08-17 Glaxo Group Limited Process for crystallizing lactose particles for use in pharmaceutical formulations
UY29440A1 (es) 2005-03-25 2006-10-02 Glaxo Group Ltd Nuevos compuestos
PE20061193A1 (es) 2005-03-25 2006-12-02 Glaxo Group Ltd DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2-[1H]-0NA COMO INHIBIDORES DE QUINASA p38
US20090308772A1 (en) * 2006-03-17 2009-12-17 Abrams William S Moisture-tight primary packaging for a dry powder inhaler
US8251059B2 (en) 2006-06-27 2012-08-28 Otsuka Pharmaceutical Co., Ltd. Powder inhaler
GB0625303D0 (en) * 2006-12-19 2007-01-24 Jagotec Ag Improvements in and relating to metered dose inhalers
PE20081889A1 (es) 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
EP2058025B1 (en) * 2007-11-09 2014-09-03 Hitachi Ltd. Powder medicine administering apparatus
GB0800457D0 (en) * 2008-01-11 2008-02-20 Innovata Biomed Ltd Improvements in or relating to inhalers
PT3578169T (pt) 2009-02-26 2024-07-29 Glaxo Group Ltd Formulações farmacêuticas compreendendo 4-{(1r)-2-[(2,6- diclorobenzil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2- (hidroximetil)fenol
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
EP2611423B2 (en) 2010-08-31 2022-09-21 GlaxoSmithKline Intellectual Property Development Limited Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
EP3461474B1 (en) 2010-08-31 2020-11-11 GlaxoSmithKline Intellectual Property Development Limited Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
JP2015522362A (ja) * 2012-07-20 2015-08-06 サノフィ・ソシエテ・アノニム 吸入デバイス用の計量要素および計量要素を含む吸入デバイス
SG11201503697TA (en) 2012-11-28 2015-06-29 Intercept Pharmaceuticals Inc Treatment of pulmonary disease
TW201625247A (zh) 2014-05-12 2016-07-16 葛蘭素史密斯克藍智慧財產權有限公司 用於治療傳染性疾病之醫藥組合物
WO2016142426A1 (en) 2015-03-11 2016-09-15 Glaxosmithkline Intellectual Property Development Limited Tslp binding proteins
CN107709306A (zh) 2015-06-15 2018-02-16 葛兰素史密斯克莱知识产权发展有限公司 Nrf2调节剂
CA2988338C (en) 2015-06-15 2024-05-14 Glaxosmithkline Intellectual Property Development Limited Nrf2 regulators
EP3766878B1 (en) 2015-06-15 2022-03-16 GlaxoSmithKline Intellectual Property Development Limited Nrf2 regulators
TW201722965A (zh) 2015-08-16 2017-07-01 葛蘭素史密斯克藍智慧財產發展有限公司 用於抗菌應用之化合物
JP2018529744A (ja) 2015-10-06 2018-10-11 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ Ｎｒｆ２レギュレーターとしてのアリールシクロヘキシルピラゾール
EP3359532A1 (en) 2015-10-06 2018-08-15 GlaxoSmithKline Intellectual Property Development Limited Biaryl pyrazoles as nrf2 regulators
TW201825458A (zh) 2016-09-20 2018-07-16 英商葛蘭素史克智慧財產（第二）有限公司 Ｔｒｐｖ４拮抗劑
CN109790116B (zh) 2016-09-20 2022-10-28 葛兰素史密斯克莱知识产权（第2 号）有限公司 Trpv4拮抗剂
EP3515889A1 (en) 2016-09-20 2019-07-31 GlaxoSmithKline Intellectual Property (No. 2) Limited Trpv4 antagonists
KR20190088404A (ko) 2016-12-06 2019-07-26 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 3-(2,3-디히드로-1h-인덴-5-일)프로판산 유도체 및 nrf2 조절제로서의 그의 용도
US20200031820A1 (en) 2016-12-12 2020-01-30 Glsxosmithkline Intellectual Property Development Limited 3-carboxylic acid pyrroles as nrf2 regulators
US20200071310A1 (en) 2016-12-12 2020-03-05 Glaxosmithkline Intellectual Property Development Limited N-aryl pyrazoles as nrf2 regulators
US20220002272A1 (en) 2016-12-14 2022-01-06 Glaxosmithkline Intellectual Property Development Limited Bisaryl lactams as nrf2 activators
JP2020502123A (ja) 2016-12-14 2020-01-23 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ Ｎｒｆ２アクチベーターとしてのビスアリール複素環
US11078216B2 (en) 2016-12-14 2021-08-03 Glaxosmithkline Intellectual Property Development Limited Bisaryl amides as NRF2 activators
US11028099B2 (en) 2016-12-15 2021-06-08 Glaxosmithkline Intellectual Property Development Limited NRF2 activators
JP2020502152A (ja) 2016-12-15 2020-01-23 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ Ｎｒｆ２アクチベーターとしてのエーテル結合トリアゾール
US20210177861A1 (en) 2017-12-11 2021-06-17 Glaxosmithkline Intellectual Property Development Limited Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
WO2019116231A1 (en) 2017-12-11 2019-06-20 Glaxosmithkline Intellectual Property Development Limited Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
GB201720989D0 (en) 2017-12-15 2018-01-31 Glaxosmithkline Ip Dev Ltd Chemical compounds
CN111868063B (zh) 2018-01-17 2023-08-01 葛兰素史克知识产权开发有限公司 PI4KIIIβ抑制剂
EP3796906A1 (en) 2018-05-23 2021-03-31 GlaxoSmithKline Intellectual Property Management Limited Indanes as nrf2 activators
GB201908536D0 (en) 2019-06-13 2019-07-31 Glaxosmithkline Ip Dev Ltd Compounds
EP4138884A1 (en) 2020-04-20 2023-03-01 Sorrento Therapeutics, Inc. Pulmonary administration of ace2 polypeptides
WO2022175425A1 (en) 2021-02-22 2022-08-25 Glaxosmithkline Intellectual Property Development Limited Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection
EP4452373B1 (en) * 2021-12-21 2026-02-11 Chiesi Farmaceutici S.p.A. Powder inhaler
US12502490B2 (en) 2022-04-29 2025-12-23 Merxin Ltd Manifold

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1587657A (es) 1968-08-01 1970-03-27
US3662915A (en) 1970-10-08 1972-05-16 Dougherty Bros Tamper proof package
US3840152A (en) * 1973-06-18 1974-10-08 None Such Enterprises Inc Sealable and resealable container
US4491238A (en) * 1983-12-12 1985-01-01 Tobolt Michael J Receptacle having a plug closure
US4762248A (en) 1987-05-11 1988-08-09 Plastic Technologies Tamper resistant wide mouth package
US5421482A (en) * 1989-02-03 1995-06-06 Senetics, Inc. Indicator device responsive to axial force
US5718355A (en) * 1989-02-03 1998-02-17 Senetics, Inc. Indicator device responsive to axial force for use with inhaler
SE466684B (sv) * 1989-03-07 1992-03-23 Draco Ab Anordning vid en inhalator samt foerfarande foer att med anordningen registrera medicinering med inhalator
CH682227A5 (en) * 1990-11-23 1993-08-13 Edy Scheller Ag Plastics bottle closure - has closure part fixed to bottle neck with lower securing strip preventing unauthorised removal from neck
US5394868A (en) * 1992-06-25 1995-03-07 Schering Corporation Inhalation device for powdered medicaments
DE69331635T2 (de) * 1992-11-12 2002-10-31 Minnesota Mining And Mfg. Co., Saint Paul Pulverinhalator
WO1994014492A2 (en) * 1992-12-18 1994-07-07 Schering Corporation Inhaler for powdered medications
US5524613A (en) * 1993-08-25 1996-06-11 Habley Medical Technology Corporation Controlled multi-pharmaceutical inhaler
CA2172537A1 (en) * 1993-09-22 1995-03-30 Gage Garby Indicator device responsive to axial force
DE69529104T2 (de) 1994-09-16 2003-07-17 Laboratoire Glaxosmithkline S.A.S., Marly-Le-Roi Inhalator

Also Published As

Publication number Publication date
AP2002002693A0 (en) 2002-12-31
AR017446A2 (es) 2001-09-05
TR199901582T2 (xx) 1999-09-21
AP1259A (en) 2004-04-23
HUP0000885A3 (en) 2001-02-28
ID22851A (id) 1999-12-09
EP1378260A2 (en) 2004-01-07
TW404843B (en) 2000-09-11
PL187248B1 (pl) 2004-06-30
ATE279954T1 (de) 2004-11-15
CO5080756A1 (es) 2001-09-25
US6321747B1 (en) 2001-11-27
EP1378260B1 (en) 2005-09-07
DE69827112D1 (de) 2004-11-25
PL334447A1 (en) 2000-02-28
HRP980382A2 (en) 1999-10-31
AP1165A (en) 2003-06-30
IS5103A (is) 1999-06-30
WO1998030262A3 (en) 1998-10-15
CN1478557A (zh) 2004-03-03
EP0954348B1 (en) 2004-10-20
AR011372A1 (es) 2000-08-16
NZ336507A (en) 2001-09-28
PL187815B1 (pl) 2004-10-29
EP1378260A3 (en) 2004-01-21
IL130687A (en) 2003-09-17
PE20030179A1 (es) 2003-04-07
NO993348L (no) 1999-07-07
CA2277150A1 (en) 1998-07-16
AP9901596A0 (en) 1999-09-30
IL130687A0 (en) 2000-06-01
JP2001507966A (ja) 2001-06-19
DE69831517D1 (de) 2005-10-13
EA001286B1 (ru) 2000-12-25
HU222771B1 (hu) 2003-10-28
KR20000069973A (ko) 2000-11-25
YU32399A (sh) 2001-05-28
GB9700226D0 (en) 1997-02-26
DE69831517T2 (de) 2006-06-08
CZ2000298A3 (cs) 2000-05-17
EA001291B1 (ru) 2000-12-25
ATE303838T1 (de) 2005-09-15
CN1249694A (zh) 2000-04-05
BR9806864A (pt) 2000-04-18
HRP980382B1 (en) 2002-06-30
NO993348D0 (no) 1999-07-07
TR200000032T2 (tr) 2000-07-21
HUP0000885A2 (hu) 2000-08-28
DE69827112T2 (de) 2005-03-24
WO1998030262A2 (en) 1998-07-16
EA200000229A1 (ru) 2000-08-28
EP0954348A2 (en) 1999-11-10
EA199900515A1 (ru) 2000-04-24

Similar Documents

Publication Publication Date Title
PE39599A1 (es) Dispositivo de inhalacion
MX9701957A (es) Dispostivo de inhalacion.
MX9300908A (es) Dispositivo dosificador.
MX9707864A (es) Inhalador de dosis medida por salmeterol.
ES2179192T3 (es) Inhibidor dosificador para albuterol.
AR064901A2 (es) Una pelicula consumible adaptada para disolverse en la boca de un consumidor
GB2359987B (en) Interdental brush
PE98899A1 (es) Un sistema de suministro para una sustancia para el cuidado bucal que utiliza una tira de material que tiene baja rigidez en flexion
AU3157793A (en) Powder inhaler using powder carriers with regular surface microfeatures
CO4940364A1 (es) Sistema de suministro de una substancia blanqueadora de dientes usando una tira de material que tiene baja rigidez en flexion
AR020051A1 (es) Procedimiento de uso y uso de una combinacion de un anticuerpo anti-erbb2 y un agente quimicoterapeutico distinto de un derivado de antraciclina para la manufactura de un medicamento util para el tratamiento de cancer
AR044678A1 (es) Toalla higienica delgada que tiene prominencias
ES2155243T3 (es) Dispositivo para el maquillaje de los labios.
MXPA04005969A (es) Conector medico.
AU5816194A (en) Device for dropwise delivery of a fluid contained in a flexible vial
MX9305473A (es) Dispositivo distribuidor de medicamentos.
FR2846205B1 (fr) Dispositif de conditionnement et d'application comportant un corps contenant des particules
AR021768A1 (es) Soporte de principio activo en forma de lamina
MXPA03003911A (es) Polvo en contra de los hongos que tiene propiedades de excipiente mejoradas.
HUP0101096A2 (hu) Orrspray-készülék elasztomer szeleppel
GB0100397D0 (en) Medical respiratory apparatus
KR101850625B1 (ko) 구강 건강용 마우스피스
MX2023004444A (es) Articulo para el cuidado bucal que comprende un portador de suministro hidrofobo y particulas hidrofilas solidas que comprenden un agente blanqueador.
DE50109992D1 (de) Verwendung einer Spritze für medizinische Zwecke in Verbindung mit einer Transportvorrichtung
MX2008002465A (es) Instrumento para el cuidado oral que incluye un agente para el cuidado oral.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed